Which marketing claims are allowed for EMS face lifting devices?

A permanent-lift statement is generally high risk because it describes a lasting physiological or structural outcome that requires strong, appropriately designed evidence and may move the product beyond a cosmetic positioning. Safer wording may describe a temporary improvement in the appearance of firmness or facial contour, but only when the product’s testing supports that result and the wording matches the destination market’s rules. Avoid implying surgery, tissue remodeling, or a guaranteed duration unless those points have been specifically substantiated. Product images should also avoid misleading before-and-after presentation, unusual lighting, or retouching that exaggerates the expected effect.

The evidence should connect the exact marketed statement to the actual device, accessories, settings, population, and use instructions. Technical specifications can support statements about an output mode or electrical stimulation function, but they do not by themselves prove visible lifting, wrinkle reduction, or improved contour. For performance claims, buyers should consider a documented test protocol, defined endpoints, appropriate controls, representative users, treatment duration, adverse-event recording, and a reproducible analysis. Evidence generated on another device or a different waveform should not automatically be transferred. Keep the approved claim, test report, version number, and labeling revision traceable in the technical documentation.

Not automatically, but the wording and context matter. A limited cosmetic statement such as improving the appearance of fine lines may be treated differently from a claim that the device treats wrinkles as a condition, repairs skin, stimulates collagen, or changes tissue structure. Images, influencer scripts, brochures, and distributor listings can expand the implied claim beyond the product label. Regulators assess the overall presentation, not only one isolated sentence. Before publication, classify each statement as cosmetic, functional, or medical, then check whether the intended use, risk assessment, evidence, and market authorization support that category.

Before-and-after imagery can be used only when it represents reasonably expected results and is presented with conditions that do not mislead viewers. The same camera position, lighting, facial expression, makeup status, treatment schedule, and follow-up timing should be controlled as far as practical. Consent and privacy rights must be documented, and retouching should not alter the claimed outcome. A disclaimer cannot cure an image that creates a materially false impression. The accompanying text should identify whether the result is temporary, individual, or based on a limited evaluation rather than implying that every customer will obtain the pictured change.

Words such as “guaranteed,” “permanent,” “cures,” “reverses aging,” “repairs tissue,” and “works for everyone” create avoidable compliance risk because they imply certainty, disease treatment, structural change, or universal performance. “FDA approved” should not be used unless the specific product and claim have the required status; a factory certificate or general registration is not equivalent. Terms such as “non-invasive” describe a characteristic but do not prove effectiveness or safety for every user. Build a claim matrix that links each proposed phrase to its evidence, intended use, market, label, and required qualification.

There is no single global permission for advertising language. In the European Union, the intended purpose stated by the manufacturer influences whether a product falls under medical-device rules, while cosmetic presentation remains subject to broader consumer and advertising requirements. In the United States, intended use and promotional claims can affect FDA status, and advertising may also be reviewed under Federal Trade Commission substantiation principles. Other markets may require local registration, importer review, language controls, or specific evidence. Prepare market-specific labels and web copy rather than translating one master claim set without regulatory review.